See All Slides - tctmd.com

Slides

Presentation TCT 2012

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Presenter: Hendrik Treede

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

New Insights into Normal and Diseased Mitral Valve Anatomy

Presenter: David Adams

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

Presenter: Giulio Stefanini

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

Presenter: Jai-Wun Park

October 23, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR?

Presenter: Michael Rinaldi

October 23, 2012

Advertisement

Slides

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Pathogenesis of Vulnerable Plaque 2012: What's New?

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

New Insights into Normal and Diseased Mitral Valve Anatomy

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content